Cabot Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-11,808
| Closed | -$978K | – | 140 |
|
|
2016
Q4 | $978K | Sell |
11,808
-2,553
| -18% | -$211K | 0.26% | 85 |
|
|
2016
Q3 | $1.33M | Sell |
14,361
-719
| -5% | -$66.5K | 0.34% | 85 |
|
|
2016
Q2 | $1.17M | Sell |
15,080
-232
| -2% | -$18K | 0.31% | 84 |
|
|
2016
Q1 | $1.26M | Sell |
15,312
-22,247
| -59% | -$1.84M | 0.35% | 75 |
|
|
2015
Q4 | $3.94M | Buy |
37,559
+15,413
| +70% | +$1.61M | 1.01% | 39 |
|
|
2015
Q3 | $2.33M | Sell |
22,146
-329
| -1% | -$34.6K | 0.64% | 63 |
|
|
2015
Q2 | $3.07M | Sell |
22,475
-137
| -0.6% | -$18.7K | 0.75% | 56 |
|
|
2015
Q1 | $2.82M | Sell |
22,612
-164
| -0.7% | -$20.4K | 0.69% | 56 |
|
|
2014
Q4 | $2.06M | Sell |
22,776
-26,773
| -54% | -$2.42M | 0.51% | 77 |
|
|
2014
Q3 | $3.58M | Sell |
49,549
-779
| -2% | -$56.2K | 0.91% | 46 |
|
|
2014
Q2 | $3.13M | Buy |
50,328
+1,119
| +2% | +$69.6K | 0.79% | 61 |
|
|
2014
Q1 | $3.36M | Sell |
49,209
-162
| -0.3% | -$11.1K | 0.88% | 50 |
|
|
2013
Q4 | $3.47M | Sell |
49,371
-62
| -0.1% | -$4.36K | 0.91% | 47 |
|
|
2013
Q3 | $3.57M | Buy |
49,433
+16,640
| +51% | +$1.2M | 1.07% | 29 |
|
|
2013
Q2 | $1.83M | Buy |
+32,793
| New | +$1.83M | 0.63% | 67 |
|